Evidence map›Paper›PMID 40346191›Full record

ArticleScientific reports2025

Disposable e-cigarettes and their nicotine delivery, usage pattern, and subjective effects in occasionally smoking adults.

Christin Falarowski, Elke Pieper, Andrea Rabenstein, Nadja Mallock-Ohnesorg, Nestor Burgmann, Klaas Franzen, Marcus Gertzen, Gabriele Koller, Dennis Nowak, Anna Rahofer and 7 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Vaping ΔExpert review of clinical pharmacology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Christin Falarowski *Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Elke Pieper *Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Andrea RabensteinDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany. Andrea.Rabenstein@med.uni-muenchen.de.
Nadja Mallock-OhnesorgDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Nestor BurgmannDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Klaas FranzenMedical Clinic III, University Hospital Schleswig-Holstein, Campus Lübeck, 23562, Lübeck, Germany.
Marcus GertzenDepartment of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, University of Augsburg, Geschwister-Schönert-Str. 1, 86159, Augsburg, Germany.
Gabriele KollerDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Dennis NowakInstitute of Occupational, Social and Environmental Medicine, CPC (Comprehensive Pneumology Center) Munich, LMU University Hospital, LMU Munich, DZL (Deutsches Zentrum für Lungenforschung), Munich, Germany.
Anna RahoferDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Benedikt RiederDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Gabriel Roselli de Oliveira Pinto KiseDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Thomas SchulzDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Elena StrohmeyerDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Peter LauxDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Andreas LuchDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Tobias RütherDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New disposable e-cigarettes are popular, especially among young people. This study aimed to assess their addictive potential by examining puffing behaviors, subjective effects, and conducting laboratory investigations in an experimental setting. Single-center, four-arm, crossover study. Laboratory setting in Munich (LMU-University Hospital), Germany. Eighteen occasionally cigarette-smoking adults aged 19-28. Two disposable e-cigarettes of the same brand (strawberry-kiwi/ tobacco flavored) were tested with a cigarette and a conventional pod e-cigarette as comparators. Usage was ad libitum for 5 min (or the duration of smoking one cigarette) while puffing topography was recorded. Distributed over 30 min blood samples for nicotine plasma concentrations were drawn and hemodynamic parameters and subjective effects assessed. Nicotine delivery of disposable e-cigarettes (C

Indexed as

Electronic Nicotine Delivery SystemsNicotineSmokingVapingAdultCross-Over StudiesFemaleGermanyHumansMaleYoung AdultNicotine

Identifiers

PMID40346191
PMCPMC12064830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.